Temporal evolution and factors influencing visual function and RNFL thickness in ethambutol-associated optic neuropathy

Abstract Purpose This study aimed to investigate the temporal evolution and influencing factors of visual function and optic nerve structure in ethambutol-associated optic neuropathy (EON). Methods In this single-center retrospective observational study, we analyzed data from 48 EON patients (26 mal...

Full description

Saved in:
Bibliographic Details
Main Authors: Taimin Guo, Yue Fu, Xiaoyu Xu, Xiaoning Liu, Yurong Zhang, Hui Yang
Format: Article
Language:English
Published: BMC 2025-04-01
Series:European Journal of Medical Research
Subjects:
Online Access:https://doi.org/10.1186/s40001-025-02573-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849713058747777024
author Taimin Guo
Yue Fu
Xiaoyu Xu
Xiaoning Liu
Yurong Zhang
Hui Yang
author_facet Taimin Guo
Yue Fu
Xiaoyu Xu
Xiaoning Liu
Yurong Zhang
Hui Yang
author_sort Taimin Guo
collection DOAJ
description Abstract Purpose This study aimed to investigate the temporal evolution and influencing factors of visual function and optic nerve structure in ethambutol-associated optic neuropathy (EON). Methods In this single-center retrospective observational study, we analyzed data from 48 EON patients (26 males and 22 females) with a 12-month follow-up. Comprehensive ophthalmologic assessments, including best corrected visual acuity (BCVA), visual field (VF), optical coherence tomography (OCT), and magnetic resonance imaging (MRI), were conducted to evaluate visual function and optic nerve structure. Statistical analyses including multiple linear regression and comparative analyses (independent t-tests/Mann–Whitney U tests) were performed to identify factors influencing recovery, with effect sizes calculated using Cohen’s d. Results Significant improvements in best corrected visual acuity and visual field were observed between 3 and 6 months. The mean improvement in BCVA was 0.25 logMAR (from 1.28 ± 0.64 at 3 months to 0.82 ± 0.60 at 6 months, p < 0.0001, Cohen’s d = 0.74, 95% CI [0.33, 1.15]), and the mean improvement in VF mean deviation was 2.5 dB (from − 13.85 ± 9.23 dB at 3 months to − 10.33 ± 7.58 dB at 6 months, p = 0.037, Cohen’s d = 0.42, 95% CI [0.11, 6.93]), indicating a critical recovery window. Peripapillary retinal nerve fiber layer (pRNFL) thinning was most pronounced between 3 and 9 months, with the temporal quadrant showing the earliest thinning (40.21% reduction by 3 months). Macular ganglion cell-inner plexiform layer (mGCIPL) thickness showed a decreasing trend (73.20 ± 4.76 μm to 55.33 ± 4.16 μm) from 1 month post-onset. Multivariate analysis revealed that disease course was the primary factor influencing VF recovery (β = − 0.31, p = 0.001), while peripapillary retinal nerve fiber layer thinning was associated with gender, ethambutol dosage, and disease duration. Female patients exhibited slower peripapillary retinal nerve fiber layer thinning compared to males. Conclusions This study identifies a critical recovery window for visual function in EON between 3 and 6 months, with peripapillary retinal nerve fiber layer thinning progressing significantly between 3 and 9 months. The temporal quadrant of the peripapillary retinal nerve fiber layer may serve as an early marker for disease progression. These findings provide valuable insights for optimizing monitoring and intervention strategies in EON patients, highlighting that early therapeutic interventions—particularly for patients showing temporal RNFL thinning or high-risk features—may maximize visual recovery potential.
format Article
id doaj-art-d5fc3ab1e7724f25b31425cb83218cb8
institution DOAJ
issn 2047-783X
language English
publishDate 2025-04-01
publisher BMC
record_format Article
series European Journal of Medical Research
spelling doaj-art-d5fc3ab1e7724f25b31425cb83218cb82025-08-20T03:14:05ZengBMCEuropean Journal of Medical Research2047-783X2025-04-0130111210.1186/s40001-025-02573-9Temporal evolution and factors influencing visual function and RNFL thickness in ethambutol-associated optic neuropathyTaimin Guo0Yue Fu1Xiaoyu Xu2Xiaoning Liu3Yurong Zhang4Hui Yang5State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular DiseasesState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular DiseasesState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular DiseasesState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular DiseasesState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular DiseasesState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular DiseasesAbstract Purpose This study aimed to investigate the temporal evolution and influencing factors of visual function and optic nerve structure in ethambutol-associated optic neuropathy (EON). Methods In this single-center retrospective observational study, we analyzed data from 48 EON patients (26 males and 22 females) with a 12-month follow-up. Comprehensive ophthalmologic assessments, including best corrected visual acuity (BCVA), visual field (VF), optical coherence tomography (OCT), and magnetic resonance imaging (MRI), were conducted to evaluate visual function and optic nerve structure. Statistical analyses including multiple linear regression and comparative analyses (independent t-tests/Mann–Whitney U tests) were performed to identify factors influencing recovery, with effect sizes calculated using Cohen’s d. Results Significant improvements in best corrected visual acuity and visual field were observed between 3 and 6 months. The mean improvement in BCVA was 0.25 logMAR (from 1.28 ± 0.64 at 3 months to 0.82 ± 0.60 at 6 months, p < 0.0001, Cohen’s d = 0.74, 95% CI [0.33, 1.15]), and the mean improvement in VF mean deviation was 2.5 dB (from − 13.85 ± 9.23 dB at 3 months to − 10.33 ± 7.58 dB at 6 months, p = 0.037, Cohen’s d = 0.42, 95% CI [0.11, 6.93]), indicating a critical recovery window. Peripapillary retinal nerve fiber layer (pRNFL) thinning was most pronounced between 3 and 9 months, with the temporal quadrant showing the earliest thinning (40.21% reduction by 3 months). Macular ganglion cell-inner plexiform layer (mGCIPL) thickness showed a decreasing trend (73.20 ± 4.76 μm to 55.33 ± 4.16 μm) from 1 month post-onset. Multivariate analysis revealed that disease course was the primary factor influencing VF recovery (β = − 0.31, p = 0.001), while peripapillary retinal nerve fiber layer thinning was associated with gender, ethambutol dosage, and disease duration. Female patients exhibited slower peripapillary retinal nerve fiber layer thinning compared to males. Conclusions This study identifies a critical recovery window for visual function in EON between 3 and 6 months, with peripapillary retinal nerve fiber layer thinning progressing significantly between 3 and 9 months. The temporal quadrant of the peripapillary retinal nerve fiber layer may serve as an early marker for disease progression. These findings provide valuable insights for optimizing monitoring and intervention strategies in EON patients, highlighting that early therapeutic interventions—particularly for patients showing temporal RNFL thinning or high-risk features—may maximize visual recovery potential.https://doi.org/10.1186/s40001-025-02573-9Ethambutol-induced neuropathyVisual functionPrognosisRisk factorsOptic neuropathy recovery
spellingShingle Taimin Guo
Yue Fu
Xiaoyu Xu
Xiaoning Liu
Yurong Zhang
Hui Yang
Temporal evolution and factors influencing visual function and RNFL thickness in ethambutol-associated optic neuropathy
European Journal of Medical Research
Ethambutol-induced neuropathy
Visual function
Prognosis
Risk factors
Optic neuropathy recovery
title Temporal evolution and factors influencing visual function and RNFL thickness in ethambutol-associated optic neuropathy
title_full Temporal evolution and factors influencing visual function and RNFL thickness in ethambutol-associated optic neuropathy
title_fullStr Temporal evolution and factors influencing visual function and RNFL thickness in ethambutol-associated optic neuropathy
title_full_unstemmed Temporal evolution and factors influencing visual function and RNFL thickness in ethambutol-associated optic neuropathy
title_short Temporal evolution and factors influencing visual function and RNFL thickness in ethambutol-associated optic neuropathy
title_sort temporal evolution and factors influencing visual function and rnfl thickness in ethambutol associated optic neuropathy
topic Ethambutol-induced neuropathy
Visual function
Prognosis
Risk factors
Optic neuropathy recovery
url https://doi.org/10.1186/s40001-025-02573-9
work_keys_str_mv AT taiminguo temporalevolutionandfactorsinfluencingvisualfunctionandrnflthicknessinethambutolassociatedopticneuropathy
AT yuefu temporalevolutionandfactorsinfluencingvisualfunctionandrnflthicknessinethambutolassociatedopticneuropathy
AT xiaoyuxu temporalevolutionandfactorsinfluencingvisualfunctionandrnflthicknessinethambutolassociatedopticneuropathy
AT xiaoningliu temporalevolutionandfactorsinfluencingvisualfunctionandrnflthicknessinethambutolassociatedopticneuropathy
AT yurongzhang temporalevolutionandfactorsinfluencingvisualfunctionandrnflthicknessinethambutolassociatedopticneuropathy
AT huiyang temporalevolutionandfactorsinfluencingvisualfunctionandrnflthicknessinethambutolassociatedopticneuropathy